SHENYANG, China, March 19 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX) (''3SBio'' or the ''Company''), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced the appointment of Dr. David Chen to the newly created role of Executive Vice President and Chief Operating Officer, effective immediately. Dr. Chen most recently held the position of Vice President of Business Development at 3SBio.
Since joining 3SBio in June 2007, Dr. Chen has been responsible for developing long-range growth strategies and pursuing strategic business opportunities and external alliances with biotechnology and pharmaceutical companies in major markets worldwide. In addition to his existing responsibilities, Dr. Chen will assume oversight of commercial operations including commercial strategy, medical and regulatory, government affairs, and export. He will be based in Beijing, China.
Dr. Jing Lou, CEO of 3SBio, commented, ''I am very pleased to announce
the promotion of David Chen to the position of Chief Operating Officer.
Since assuming the role of VP of Business Development, David has quickly
demonstrated his leadership skills and has played a critical role in
planning and executing our future growth strategies and partnering
initiatives, helping to establish relationships with a number of potential
partners around the world. His in-depth understanding of the Chinese
pharmaceutical market place combined with his significant operating
experience with multinational pharmaceutical companies in the US make him
the ideal candidate to assume this newly created position. I look forward
to working together with David as we help drive the next phase
|SOURCE 3SBio Inc.|
Copyright©2008 PR Newswire.
All rights reserved